EBV EARLY ANTIGEN (R+D)

Antiserum, Fluorescent, Epstein-barr Virus

HILLCREST BIOLOGICALS

The following data is part of a premarket notification filed by Hillcrest Biologicals with the FDA for Ebv Early Antigen (r+d).

Pre-market Notification Details

Device IDK884829
510k NumberK884829
Device Name:EBV EARLY ANTIGEN (R+D)
ClassificationAntiserum, Fluorescent, Epstein-barr Virus
Applicant HILLCREST BIOLOGICALS 10703 PROGRESS WAY Cypress,  CA  90630
ContactCarolyn B Wagner
CorrespondentCarolyn B Wagner
HILLCREST BIOLOGICALS 10703 PROGRESS WAY Cypress,  CA  90630
Product CodeJRY  
CFR Regulation Number866.3235 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1988-11-18
Decision Date1989-04-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.